These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19075671)

  • 1. IGF signaling pathway as a selective target of familial breast cancer therapy.
    Shukla V; Coumoul X; Vassilopoulos A; Deng CX
    Curr Mol Med; 2008 Dec; 8(8):727-40. PubMed ID: 19075671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of STAT3, β-catenin, and IGF-1R sensitize mouse PIK3CA-mutant breast cancer to PI3K inhibitors.
    Merino VF; Cho S; Liang X; Park S; Jin K; Chen Q; Pan D; Zahnow CA; Rein AR; Sukumar S
    Mol Oncol; 2017 May; 11(5):552-566. PubMed ID: 28296140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin-like growth factor system as a target in breast cancer.
    Yee D
    Breast Cancer Res Treat; 1994; 32(1):85-95. PubMed ID: 7529598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic strategies to interrupt insulin-like growth factor signaling in breast cancer.
    Byron SA; Yee D
    Semin Oncol; 2003 Oct; 30(5 Suppl 16):125-32. PubMed ID: 14613033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor: current concepts and new developments in cancer therapy.
    King ER; Wong KK
    Recent Pat Anticancer Drug Discov; 2012 Jan; 7(1):14-30. PubMed ID: 21875414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prospects of IGF-signaling system components study in ovarian cancer patients.
    Gershtein E; Kushlinskii N
    Drug Metab Pers Ther; 2015 Jun; 30(2):75-85. PubMed ID: 25941918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor pathway as a target for cancer therapy.
    López-Calderero I; Sánchez Chávez E; García-Carbonero R
    Clin Transl Oncol; 2010 May; 12(5):326-38. PubMed ID: 20466617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors and breast cancer therapy.
    Zeng X; Yee D
    Adv Exp Med Biol; 2007; 608():101-12. PubMed ID: 17993235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation.
    Duan C; Ren H; Gao S
    Gen Comp Endocrinol; 2010 Jul; 167(3):344-51. PubMed ID: 20403355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting insulin-like growth factor in breast cancer therapeutics.
    Karamouzis MV; Papavassiliou AG
    Crit Rev Oncol Hematol; 2012 Oct; 84(1):8-17. PubMed ID: 22424863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors and breast cancer.
    Fürstenberger G; Morant R; Senn HJ
    Onkologie; 2003 Jun; 26(3):290-4. PubMed ID: 12845216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-Like Growth Factor (IGF) family and prostate cancer.
    Gennigens C; Menetrier-Caux C; Droz JP
    Crit Rev Oncol Hematol; 2006 May; 58(2):124-45. PubMed ID: 16387509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of the IGF system as a strategy to inhibit breast cancer growth.
    Arteaga CL
    Breast Cancer Res Treat; 1992; 22(1):101-6. PubMed ID: 1421419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
    Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
    Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IGF axis and placental function. a mini review.
    Forbes K; Westwood M
    Horm Res; 2008; 69(3):129-37. PubMed ID: 18219215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations.
    Hudelist G; Wagner T; Rosner M; Fink-Retter A; Gschwantler-Kaulich D; Czerwenka K; Kroiss R; Tea M; Pischinger K; Köstler WJ; Attems J; Mueller R; Blaukopf C; Kubista E; Hengstschläger M; Singer CF
    Endocr Relat Cancer; 2007 Dec; 14(4):1053-62. PubMed ID: 18045956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo.
    Lee AV; Jackson JG; Gooch JL; Hilsenbeck SG; Coronado-Heinsohn E; Osborne CK; Yee D
    Mol Endocrinol; 1999 May; 13(5):787-96. PubMed ID: 10319328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-insulin-like growth factor strategies in breast cancer.
    Jerome L; Shiry L; Leyland-Jones B
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):54-63. PubMed ID: 15052543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
    Jernström H; Sandberg T; Bågeman E; Borg A; Olsson H
    Int J Gynecol Cancer; 2006; 16 Suppl 2():497. PubMed ID: 17010055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
    Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.